ARDT Valuation

Ardent Health Inc

Add to Watchlist

Advanced Chart

12.690

+0.16(1.277%)1D

Overview
Forecast
Valuation
Earnings

ARDT Relative Valuation

ARDT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ARDT is overvalued; if below, it's undervalued.

Historical Valuation

Ardent Health Inc (ARDT) is now in the Undervalued zone, suggesting that its current forward PE ratio of 6.74 is considered Undervalued compared with the five-year average of 8.35. The fair price of Ardent Health Inc (ARDT) is between 13.76 to 19.12 according to relative valuation methord. Compared to the current price of 12.69 USD , Ardent Health Inc is Undervalued By 7.77%.

Relative Value

Fair Zone

13.76-19.12

Current Price：12.69

7.77%

Undervalued

6.74

Trailing

Forward

6.26

EV/EBITDA

Ardent Health Inc. (ARDT) has a current EV/EBITDA of 6.26. The 5-year average EV/EBITDA is 7.69. The thresholds are as follows: Strongly Undervalued below 5.07, Undervalued between 5.07 and 6.38, Fairly Valued between 9.00 and 6.38, Overvalued between 9.00 and 10.30, and Strongly Overvalued above 10.30. The current Forward EV/EBITDA of 6.26 falls within the Undervalued range.

7.49

EV/EBIT

Ardent Health Inc. (ARDT) has a current EV/EBIT of 7.49. The 5-year average EV/EBIT is 9.13. The thresholds are as follows: Strongly Undervalued below 6.09, Undervalued between 6.09 and 7.61, Fairly Valued between 10.65 and 7.61, Overvalued between 10.65 and 12.16, and Strongly Overvalued above 12.16. The current Forward EV/EBIT of 7.49 falls within the Undervalued range.

0.28

Ardent Health Inc. (ARDT) has a current PS of 0.28. The 5-year average PS is 0.35. The thresholds are as follows: Strongly Undervalued below 0.23, Undervalued between 0.23 and 0.29, Fairly Valued between 0.41 and 0.29, Overvalued between 0.41 and 0.47, and Strongly Overvalued above 0.47. The current Forward PS of 0.28 falls within the Undervalued range.

3.31

P/OCF

Ardent Health Inc. (ARDT) has a current P/OCF of 3.31. The 5-year average P/OCF is 4.90. The thresholds are as follows: Strongly Undervalued below 3.19, Undervalued between 3.19 and 4.04, Fairly Valued between 5.76 and 4.04, Overvalued between 5.76 and 6.61, and Strongly Overvalued above 6.61. The current Forward P/OCF of 3.31 falls within the Undervalued range.

6.63

P/FCF

Ardent Health Inc. (ARDT) has a current P/FCF of 6.63. The 5-year average P/FCF is 10.80. The thresholds are as follows: Strongly Undervalued below 6.91, Undervalued between 6.91 and 8.86, Fairly Valued between 12.75 and 8.86, Overvalued between 12.75 and 14.70, and Strongly Overvalued above 14.70. The current Forward P/FCF of 6.63 falls within the Strongly Undervalued range.

Ardent Health Inc (ARDT) has a current Price-to-Book (P/B) ratio of 1.45. Compared to its 3-year average P/B ratio of 4.48 , the current P/B ratio is approximately -67.68% higher. Relative to its 5-year average P/B ratio of 4.48, the current P/B ratio is about -67.68% higher. Ardent Health Inc (ARDT) has a Forward Free Cash Flow (FCF) yield of approximately 5.95%. Compared to its 3-year average FCF yield of 5.34%, the current FCF yield is approximately 11.52% lower. Relative to its 5-year average FCF yield of 5.34% , the current FCF yield is about 11.52% lower.

1.45

P/B

Median3y

4.48

Median5y

4.48

5.95

FCF Yield

Median3y

5.34

Median5y

5.34

Competitors Valuation Multiple

The average P/S ratio for ARDT's competitors is 0.63, providing a benchmark for relative valuation. Ardent Health Inc Corp (ARDT) exhibits a P/S ratio of 0.28, which is -55.22% above the industry average. Given its robust revenue growth of 11.85%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Brookdale Senior Living Inc

National Healthcare Corp

Select Medical Holdings Corp

Performance Decomposition

Market capitalization of ARDT decreased by 30.96% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 4.55 to 5.82.

The secondary factor is the Revenue Growth, contributed 11.85%to the performance.

Overall, the performance of ARDT in the past 1 year is driven by Margin Expansion. Which is more sustainable.

11.85%

1.47B → 1.65B

Revenue Growth

27.91%

4.55 → 5.82

Margin Expansion

-70.72%

23.87 → 6.99

P/E Change

-30.96%